US Stocks
BGLC

BioNexus Gene Lab Corp Common stock

$2.17
+0.03 (+1.17%)

Volume:

15.207K ($32.91K)

Market Capitalization:

$5.12M

BioNexus Gene Lab Corp Common stock Price Chart

BioNexus Gene Lab Corp Common stock Price Chart 11:59 AM 1:19 PM 2:39 PM 3:59 PM 5:19 PM 6:39 PM 7:59 PM2.212.192.172.162.142.122.10

BioNexus Gene Lab Corp Common stock Volume Chart

BioNexus Gene Lab Corp Common stock Volume Chart 11:59 AM1:19 PM2:39 PM3:59 PM5:19 PM6:39 PM7:59 PM 5.00K4.29K3.57K2.86K2.14K1.43K714

BioNexus Gene Lab Corp Common stock Market Segments

After Hours

*No Trades in Segment

Regular Trading Hours

+0.02(+0.70%)
Open$2.15
Close$2.17
Low$2.10
Low Change-0.05 (-2.29%)
High$2.21
High Change+0.06 (+2.79%)
Range$0.11
Volume14.966K
Dollar Volume$32.40K

Premarket

+0.00(+0.00%)
Open$2.12
Close$2.12
Low$2.12
Low Change0.00 (0.00%)
High$2.12
High Change+0.00 (+0.00%)
Range$0.00
Volume241
Dollar Volume$512.08

After Hours Yesterday

+0.00(+0.00%)
Open$2.11
Close$2.11
Low$2.11
Low Change0.00 (0.00%)
High$2.11
High Change+0.00 (+0.00%)
Range$0.00
Volume243
Dollar Volume$512.73

Regular Trading Hours Yesterday

+0.11(+5.42%)
Open$2.03
Close$2.14
Low$2.03
Low Change0.00 (0.00%)
High$2.20
High Change+0.17 (+8.37%)
Range$0.17
Volume23.345K
Dollar Volume$49.96K

Premarket Yesterday

-0.01(-0.50%)
Open$2.02
Close$2.01
Low$2.01
Low Change-0.01 (-0.50%)
High$2.02
High Change+0.00 (+0.00%)
Range$0.01
Volume400
Dollar Volume$804.00

BioNexus Gene Lab Corp Common stock Statistics

Average Volume (30 Days)35222
PE Ratio (Current)-2.21
EPS (Current)-0.97
Dividend Yield0.00
Free Cash Flow-3253989
Cash Ratio1.70
Current Ratio8.30
Quick Ratio6.81
Debt to Equity0.00
Enterprise Value3905488
EV to EBITDA-1.15
EV to Sales0.41
Price to Book0.74
Price to Cash Flow-
Price to Free Cash Flow-
Price to Sales0.53
Return on Assets-0.30
Return on Equity-0.34

BioNexus Gene Lab Corp Common stock Stock Splits

There have been 2 stock splits for BioNexus Gene Lab Corp Common stock (BGLC). The last reverse stock split occured on April 7, 2025 and reduced the outstanding shares at a ratio of 10:1.

DateTypeRatio
April 7, 2025Reverse10:1
July 20, 2023Reverse12:1